Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 20, 2016 07:00 ET | Source: Horizon Pharma plc

Horizon Pharma plc Announces Pricing of Private Offering of Senior Notes

DUBLIN, Ireland, Oct. 20, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP) (“Horizon”), a biopharmaceutical company focused on improving patients’ lives by identifying, developing,...
October 13, 2016 07:45 ET | Source: Horizon Pharma plc

Horizon Pharma plc Announces Proposed Private Offering of Senior Notes and Intention to Borrow Incremental Term Loans under its Existing Senior Secured Credit Facility

DUBLIN, Ireland , Oct. 13, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP) (“Horizon”), a biopharmaceutical company focused on improving patients’ lives by identifying, developing,...
October 13, 2016 07:00 ET | Source: Horizon Pharma plc

Horizon Pharma plc Named One of the Country's Best Medium Workplaces by Fortune Magazine

DUBLIN, Ireland, Oct. 13, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and...
October 11, 2016 16:05 ET | Source: Horizon Pharma plc

Horizon Pharma plc to Host Third-Quarter 2016 Conference Call and Webcast on November 7, 2016

DUBLIN, Ireland, Oct. 11, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and...
September 29, 2016 08:00 ET | Source: Horizon Pharma plc

Horizon Pharma plc Provides Update on PBM Formulary Status for Primary Care Medicines

DUBLIN, Ireland, Sept. 29, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and...
September 12, 2016 07:00 ET | Source: Horizon Pharma plc; Raptor Pharmaceutical Corp.

Horizon Pharma plc to Acquire Raptor Pharmaceutical Corp. as Further Step in Building Leading Rare Disease Business

- Transaction valued at $9.00 per share in cash with fully diluted equity value of approximately $800 million - - Transaction is expected to be accretive to adjusted...
September 06, 2016 07:00 ET | Source: Horizon Pharma plc

Horizon Pharma plc to Participate in Morgan Stanley Global Healthcare Conference

DUBLIN, Ireland, Sept. 06, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and...
August 18, 2016 07:00 ET | Source: Horizon Pharma, Inc.

Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering RAYOS® (prednisone) Delayed-Release Tablets

DUBLIN, Ireland, Aug. 18, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and...
August 08, 2016 07:00 ET | Source: Horizon Pharma, Inc.

Horizon Pharma plc Announces Second-Quarter 2016 Financial Results

-- Second-Quarter 2016 Record Net Sales of $257.4 Million, Up 49 Percent ---- Second-Quarter 2016 GAAP Net Income of $15.0 Million; Adjusted EBITDA of $121.1 Million ---- Confirms Full-Year 2016 Net...
July 07, 2016 07:00 ET | Source: Horizon Pharma, Inc.

Horizon Pharma plc to Host Second-Quarter 2016 Conference Call and Webcast on August 8, 2016

DUBLIN, Ireland, July 07, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and...